Varun Mahajan, MD, currently serves as President and Lead Investor at Dermatiq since November 2023 and a Board Member with a focus on learning at YPO since October 2018. Mahajan holds advisory roles with Blomso and Techstars, both starting in 2024, and has been a Radiologist at Columbus Radiology since September 2016. Additional board memberships include the Columbus Symphony from October 2016 and previous positions with the Ohio Commission on Alzheimer’s and Dementia, Ohio Commission on Minority Health, and the Ohio Minority Health Vaccine Team. Mahajan was Chief Executive Officer of Mahajan Therapeutics from June 2015 to March 2023. Academic credentials include a Doctor of Medicine degree from Case Western Reserve University School of Medicine, completed between 2002 and 2006.